World's Best Scientists 2026 revealed!
Stephen J. Peroutka

Stephen J. Peroutka

D-Index & Metrics

Neuroscience

D-Index
67
Citations
17867
World Ranking
2869
National Ranking
1332

Stephen J. Peroutka publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Stephen J. Peroutka sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 196 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Stephen J. Peroutka D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen J. Peroutka sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 67 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Stephen J. Peroutka is affiliated with Stanford University in the United States and has a publication record focused on Medicine, with particular emphasis on subfields such as Economics and Econometrics, Public Health, Environmental and Occupational Health, Psychiatry and Mental Health, Cellular and Molecular Neuroscience, and Physiology.

Their recent research outputs cover various topics related to health systems, clinical research ethics, dementia and cognitive impairment, receptor mechanisms, neuroscience, and pharmaceutical economics and policy.

Frequent topics of their work include:

  • Health Systems, Economic Evaluations, Quality of Life
  • Ethics in Clinical Research
  • Dementia and Cognitive Impairment Research
  • Receptor Mechanisms and Signaling
  • Neuroscience and Neuropharmacology Research
  • Neurotransmitter Receptor Influence on Behavior
  • Pharmaceutical Economics and Policy

They have collaborated repeatedly with several co-authors, including Nicholas M. Barnes, Gordon S. Baxter, Joël Bockaert, Theresa A. Branchek, and Amy Butler.

Stephen J. Peroutka's frequent publication venues illustrate the dissemination channels of their work and include:

  • IUPHAR/BPS Guide to Pharmacology CITE
  • Contemporary Clinical Trials Communications
  • The Journal of Prevention of Alzheimer s Disease
  • Contemporary Clinical Trials
  • SSRN Electronic Journal

Highlighted recent papers authored by Stephen J. Peroutka include:

  • "Demographic comparison of subjects in FDA approval trials in the United States to disorder specific demographics using Real World Data," 2024, Contemporary Clinical Trials Communications
  • "Defining demographic cohorts in clinical trial populations using large electronic health records databases," 2022, Contemporary Clinical Trials
  • "Demographic Analysis of Industry-Sponsored Alzheimer's Disease Trial Populations in the United States," 2022, The Journal of Prevention of Alzheimer s Disease
  • "Demographic Comparison of Subjects in Fda Approval Trials in the United States to Disorder Specific Demographics Using Real World Data," 2023, SSRN Electronic Journal
  • "5-Hydroxytryptamine receptors in GtoPdb v.2023.1," 2023, IUPHAR/BPS Guide to Pharmacology CITE

Best Publications

  • Two distinct central serotonin receptors with different physiological functions

    Stephen J. Peroutka;Richard M. Lebovitz;Solomon H. Snyder

  • 5-Hydroxytryptamine receptor subtypes

    Stephen J. Peroutka

  • The effect of systemically administered recombinant human nerve growth factor in healthy human subjects

    Brent G. Petty;David R. Cornblath;Bruce T. Adornato;Vinay Chaudhry

  • Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes

    Richard E. Heuring;Stephen J. Peroutka

  • Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.

    Unknown

  • Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors

    Stephen J. Peroutka

  • Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.

    Stephen J. Peroutka

  • 5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization

    Stephen J. Peroutka

  • Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.

    Stephen J. Peroutka;Holly Newman;Hilary Harris

  • Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain.

    S.J. Peroutka;D.C. U'Prichard;D.A. Greenberg;S.H. Snyder

  • Differential effects of 5-hydroxytryptamine1A selective drugs on the 5-HT behavioral syndrome

    Lisa M. Smith;Stephen J. Peroutka

  • A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors.

    Donna Oksenberg;Scot A. Marsters;Brian F. O'Dowd;Hui Jin

  • 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

    Anne Hamik;Stephen J. Peroutka

  • Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment

    George A. Ricaurte;J. William Langston;J. William Langston;Louise E. Delanney;Ian Irwin

  • Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

    Dennis J. McKenna;Stephen J. Peroutka

  • Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans

    Unknown

  • Antiemetics: neurotransmitter receptor binding predicts therapeutic actions.

    Stephen J. Peroutka;Solomon H. Snyder

  • Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain

    Stephen J. Peroutka;Solomon H. Snyder

  • Characterization of the human 5-hydroxytryptamine1B receptor.

    H. Jin;D. Oksenberg;A. Ashkenazi;S. J. Peroutka

  • Neurotransmitter receptor binding in bovine cerebral microvessels

    Stephen J. Peroutka;Michael A. Moskowitz;Michael A. Moskowitz;John F. Reinhard;Solomon H. Snyder

  • Two distinct effects of 5-hydroxytryptamine on single cortical neurons.

    M. Frances Davies;Rudolph A. Deisz;David A. Prince;Stephen J. Peroutka

  • Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites.

    Stephen J. Peroutka;Bruce G. McCarthy

  • Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes

    D.J. Mckenna;D.B. Repke;L. Lo;S.J. Peroutka

  • 5-Hydroxytryptamine receptors.

    Stephen J. Peroutka

  • 5-Hydroxytryptamine receptor "families".

    Anne W. Schmidt;Stephen J. Peroutka

Frequent Co-Authors

Michael D. Mauk
Michael D. Mauk The University of Texas at Austin
Samuel S.-H. Wang
Samuel S.-H. Wang Princeton University
George A. Ricaurte
George A. Ricaurte Johns Hopkins University School of Medicine
Laurence H. Tecott
Laurence H. Tecott University of California, San Francisco
Roland D. Ciaranello
Roland D. Ciaranello Stanford University
David A. Prince
David A. Prince Stanford University
Richard A. Glennon
Richard A. Glennon Virginia Commonwealth University
Thomas M. Hyde
Thomas M. Hyde Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience can open doors to a range of related fields and flexible study options. For those interested in clinical psychology, a psyd online program offers a pathway to become a licensed psychologist, blending research and practical skills.

Individuals seeking to make a difference in family and relationship therapy may consider accelerated mft programs online. These allow you to gain qualifications faster and enter the workforce sooner.

If your goal is to start your career quickly, pursuing an accelerated bachelor's degree can shorten your study time without compromising quality. This is particularly useful for students eager to specialize or pivot careers.

When weighing your options, it’s essential to consider financial outcomes as well. Many neuroscience-related paths connect with some of the highest paying degrees in the world, offering great potential for stable and rewarding careers.

Best Scientists Citing Stephen J. Peroutka

Trending Scientists

Recently Published Articles